We are live on ! Find out more
GG

Gofen & Glossberg Portfolio holdings

AUM $3.89B
1-Year Est. Return 11.97%
This Fund
S&P 500
This Quarter Est. Return
+1.96%
1 Year Est. Return
-11.97%
3 Year Est. Return
+36.4%
5 Year Est. Return
+73.95%
10 Year Est. Return
AUM
$2.7B
AUM Growth
+$27.7M
Cap. Flow
-$7M
Cap. Flow %
-0.26%
Top 10 Hldgs %
24.54%
Holding
474
New
12
Increased
115
Reduced
195
Closed
19

Top Buys

Rank Stock Value
1
DD icon
DuPont de Nemours
DD
+$6.64M
2
MMM icon
3M
MMM
+$5.13M
3
CRM icon
Salesforce
CRM
+$4.32M
4
AMZN icon
Amazon
AMZN
+$3.46M
5
AVGO icon
Broadcom
AVGO
+$2.1M

Top Sells

Rank Stock Value
1
MON
Monsanto Co
MON
+$6.15M
2
GE icon
GE Aerospace
GE
+$3.4M
3
WFC icon
Wells Fargo
WFC
+$2.56M
4
IBM icon
IBM
IBM
+$2.39M
5
AGN
Allergan plc
AGN
+$1.76M

Sector Composition

Rank Sector Weight
1 Healthcare 14.59%
2 Financials 13.89%
3 Technology 12.64%
4 Industrials 11.12%
5 Consumer Staples 9.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AZN icon
176
AstraZeneca
AZN
$266B
$1.43M 0.05%
20,411
-4,200
-17% -$302K
NOV icon
177
NOV
NOV
$6.93B
$1.38M 0.05%
31,835
-1,775
-5% -$71.8K
AME icon
178
Ametek
AME
$55B
$1.36M 0.05%
18,897
VOD icon
179
Vodafone
VOD
$37.2B
$1.28M 0.05%
52,769
-1,183
-2% -$32.3K
COP icon
180
ConocoPhillips
COP
$145B
$1.25M 0.05%
17,912
+200
+1% +$13.3K
CDP icon
181
COPT Defense Properties
CDP
$4.35B
$1.23M 0.05%
42,285
-8,000
-16% -$219K
BP icon
182
BP
BP
$114B
$1.23M 0.05%
28,497
-1,398
-5% -$58.7K
IWF icon
183
iShares Russell 1000 Growth ETF
IWF
$120B
$1.21M 0.05%
33,776
GSK icon
184
GSK
GSK
$104B
$1.18M 0.04%
23,387
-1,039
-4% -$52.3K
SI
185
DELISTED
SIEMENS AKTIENGESELLSCHAFT ADS
SI
$1.17M 0.04%
17,680
-100
-0.6% -$6.59K
HSCZ icon
186
iShares Currency Hedged MSCI EAFE Small-Cap ETF
HSCZ
$240M
$1.12M 0.04%
35,900
-1,000
-3% -$31.6K
SYK icon
187
Stryker
SYK
$133B
$1.12M 0.04%
6,608
-171
-3% -$28.8K
AON icon
188
Aon
AON
$78.3B
$1.09M 0.04%
7,952
-50
-0.6% -$7.04K
MSCI icon
189
MSCI
MSCI
$41.9B
$1.09M 0.04%
6,565
BAX icon
190
Baxter International
BAX
$13.8B
$1.08M 0.04%
14,689
UNH icon
191
UnitedHealth
UNH
$383B
$1.08M 0.04%
4,396
-500
-10% -$120K
NSC icon
192
Norfolk Southern
NSC
$75B
$1.08M 0.04%
7,130
CPRT icon
193
Copart
CPRT
$27.4B
$1.07M 0.04%
75,360
VCSH icon
194
Vanguard Short-Term Corporate Bond ETF
VCSH
$44.8B
$1.01M 0.04%
12,939
-1,352
-9% -$106K
ILF icon
195
iShares Latin America 40 ETF
ILF
$3.85B
$1.01M 0.04%
34,140
-450
-1% -$15.2K
BAC icon
196
Bank of America
BAC
$433B
$1.01M 0.04%
35,748
-559
-2% -$16.7K
VSS icon
197
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
$11.3B
$987K 0.04%
8,553
-270
-3% -$32.3K
HYI
198
Western Asset High Yield Opportunity Fund Inc
HYI
$133M
$950K 0.04%
65,135
+269
+0.4% +$3.94K
EOG icon
199
EOG Resources
EOG
$77.5B
$941K 0.03%
7,562
-100
-1% -$11.6K
ISRG icon
200
Intuitive Surgical
ISRG
$126B
$933K 0.03%
5,850

Similar funds

Gofen & Glossberg's Q2 2018 Portfolio in Review

As of Q2 2018, Gofen & Glossberg held 474 positions worth $2.7B, up 1% from $2.67B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Gofen & Glossberg's Q2 2018 filing shows 12 new, 115 increased, 195 reduced and 19 closed positions. Its largest new stake was Evergy: 8,447 shares worth $474K. The largest sale was Monsanto Co, an estimated $6.15M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 15% a quarter earlier, followed by Financials and Technology.

  • Gofen & Glossberg's largest Q2 2018 buy was Evergy: 8,447 shares worth $474K.
  • Gofen & Glossberg added most to DuPont de Nemours in Q2 2018, an estimated $6.64M increase.
  • Gofen & Glossberg's biggest Q2 2018 reduction was GE Aerospace, cutting an estimated $3.4M.
  • Gofen & Glossberg fully exited Monsanto Co in Q2 2018, selling an estimated $6.15M.
  • Gofen & Glossberg's ten largest holdings make up 25% of its $2.7B portfolio in Q2 2018.
  • Gofen & Glossberg opened 12 new positions and closed 19 in Q2 2018.
  • Gofen & Glossberg's portfolio value rose 1% quarter-over-quarter to $2.7B.

Based on Gofen & Glossberg's 13F filing for Q2 2018, filed 11 Jul 2018.